UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors

International journal of cancer, 2013-10, Vol.133 (8), p.1936-1944

2013

Volltextzugriff (PDF)

A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma

Targeted oncology, 2014-09, Vol.9 (3), p.239-249

2014

Volltextzugriff (PDF)

A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma

Clinical cancer research, 2005-05, Vol.11 (10), p.3879-3888

2005

Volltextzugriff (PDF)

Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16×33 Bispecific Killer Cell Engager and ADAM17 Inhibition

Clinical cancer research, 2013-07, Vol.19 (14), p.3844-3855

2013

Volltextzugriff (PDF)

Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv

Clinical cancer research, 2007-05, Vol.13 (10), p.3058-3067

2007

Volltextzugriff (PDF)

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia

Blood, 2010-10, Vol.116 (14), p.2484-2493

2010

Volltextzugriff (PDF)

Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma

Oral oncology, 2012-12, Vol.48 (12), p.1202-1207

2012

Volltextzugriff (PDF)

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia

Blood, 2009-10, Vol.114 (18), p.3793-3802

2009

Volltextzugriff (PDF)

Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells

Cancer biotherapy & radiopharmaceuticals, 2013-05, Vol.28 (4), p.274-282

2013

Volltextzugriff (PDF)

Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain: Laboratory investigation

Journal of neurosurgery, 2011-06, Vol.114 (6), p.1662-1671

2011

Volltextzugriff (PDF)

Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody

Clinical cancer research, 2005-11, Vol.11 (21), p.7920-7928

2005

Volltextzugriff (PDF)

Targeting Urokinase-Type Plasminogen Activator Receptor on Human Glioblastoma Tumors With Diphtheria Toxin Fusion Protein DTAT

JNCI : Journal of the National Cancer Institute, 2002-04, Vol.94 (8), p.597-606

2002

Volltextzugriff (PDF)

Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice

International journal of cancer, 2007-01, Vol.120 (2), p.411-419

2007

Volltextzugriff (PDF)

Immunotoxin pharmacokinetics : a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13

Journal of neuro-oncology, 2006-05, Vol.77 (3), p.257-266

2006

Volltextzugriff (PDF)

Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer

Blood, 1998-11, Vol.92 (10), p.3949-3959

1998

Volltextzugriff (PDF)

Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor-immunotoxin target gene

Human gene therapy, 2002-03, Vol.13 (4), p.497-508

2002

Volltextzugriff (PDF)

The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells

Leukemia research, 2003, Vol.27 (1), p.79-84

2003

Volltextzugriff (PDF)

Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse

Diabetes (New York, N.Y.), 1992-04, Vol.41 (4), p.457-464

1992

Volltextzugriff (PDF)

Retroviral immunotoxin gene therapy of leukemia in mice using leukemia-specific T cells transduced with an interleukin-3/Bax fusion protein gene

Human gene therapy, 2003-12, Vol.14 (18), p.1787-1798

2003

Volltextzugriff (PDF)

Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene

Cancer research (Chicago, Ill.), 2000-02, Vol.60 (4), p.976-984

2000

Volltextzugriff (PDF)

Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7

Cancer research (Chicago, Ill.), 1992-03, Vol.52 (5), p.1314-1321

1992

Volltextzugriff (PDF)

Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin

Journal of neuro-oncology, 1998-10, Vol.40 (1), p.1-9

1998

Volltextzugriff (PDF)

Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice

Blood, 1998-11, Vol.92 (10), p.3960-3967

1998

Volltextzugriff (PDF)

In Vivo Blockade of CD28/CTLA4: B7/BB1 Interaction With CTLA4-Ig Reduces Lethal Murine Graft-Versus-Host Disease Across the Major Histocompatibility Complex Barrier in Mice

Blood, 1994-06, Vol.83 (12), p.3815-3825

1994

Volltextzugriff (PDF)

Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2

Cancer research (Chicago, Ill.), 1993-09, Vol.53 (18), p.4273-4280

1993

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(26)
Transplantation
(10)
Cancer Research
(9)
Clinical Cancer Research
(6)
Journal Of Neuro-Oncology
(3)
Leukemia Research
(3)
Human Gene Therapy
(2)
International Journal Of Cancer
(2)
Cancer Biotherapy & Radiopharmaceuticals
(1)
Diabetes
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors

A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma

A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma

Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16×33 Bispecific Killer Cell Engager and ADAM17 Inhibition

Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia

Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia

Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells

Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain: Laboratory investigation

Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody

Targeting Urokinase-Type Plasminogen Activator Receptor on Human Glioblastoma Tumors With Diphtheria Toxin Fusion Protein DTAT

Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice

Immunotoxin pharmacokinetics : a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13

Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer

Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor-immunotoxin target gene

The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells

Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse

Retroviral immunotoxin gene therapy of leukemia in mice using leukemia-specific T cells transduced with an interleukin-3/Bax fusion protein gene

Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene

Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7

Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin

Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice

In Vivo Blockade of CD28/CTLA4: B7/BB1 Interaction With CTLA4-Ig Reduces Lethal Murine Graft-Versus-Host Disease Across the Major Histocompatibility Complex Barrier in Mice

Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2

Aktive Filter

Suchergebnisse filtern